Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston blog main
life sciences
national blog main
san francisco blog main
san francisco top stories
7
×
boston top stories
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
startups
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
investing
merck
pfizer
president trump
roche
san francisco
abbvie
albert bourla
bristol-myers squibb
cancer
cancer immunotherapy
What
today
7
×
drug
annual
available
big
bio
biotech
cancer
clinical
crispr
future
launch
medical
oncology
roundup
society
treatments
acquisitions
ahead
aiming
albert
ambien
ambys
american
asco
attendees
attention
away
balance
based
biggest
biome
biosciences
blood
bourla
breast
bringing
camp’s
cancer's
cas
Language
unknown
unset
Current search:
biotech
×
today
×
" san francisco top stories "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More